Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coronary stenting and inflammation.

Achille Gaspardone1, Francesco Versaci

  • 1Division of Cardiology and S. Eugenio Hospital, ASL Room C, piazzale dell'Umanesimo 10, 00144 Rome, Italy. a_gaspardone@yahoo.com

The American Journal of Cardiology
|January 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tailoring Antiplatelet Therapy Duration After PFO Closure: Insights From the PROLONG Registry.

JACC. Advances·2026
Same author

Inhibition of late sodium current (INa) to prevent coronary MICROvascular dysfunction in patients presenting with ST-elevation myocardial infarction and multivessel disease: A phase IIb multicenter, randomized, controlled and open label study (INaMICRON).

International journal of cardiology·2026
Same author

Use of cangrelor in patients with reduced renal function: Post-hoc analysis from the ARCANGELO study.

International journal of cardiology·2026
Same author

Persisting Sex Discrepancies in Short-Term Outcomes of Patients with ST-Segment Myocardial Infarction: Results of the ISACS-STEMI COVID-19 Registry.

Journal of clinical medicine·2026
Same author

SGLT2 Inhibitors in Cardio-Oncology: A Systematic Review and Meta-Analysis.

JACC. Advances·2026
Same author

A leap into the future: excluding the ischaemic origin of chest pain through artificial intelligence.

European heart journal supplements : journal of the European Society of Cardiology·2026
Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026
Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026
Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026
Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026
Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026
See all related articles

Inflammation drives restenosis after coronary stenting. Individual inflammatory responses predict outcomes, suggesting personalized anti-inflammatory therapies based on markers like C-reactive protein are crucial for better patient results.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Biomarkers

Background:

  • Neointimal proliferation through stent struts is the primary cause of restenosis post-stent implantation.
  • Inflammatory mechanisms are increasingly recognized as central to neointimal proliferation and restenosis development.
  • Coronary stenting acts as a significant inflammatory stimulus, eliciting acute local and systemic responses.

Purpose of the Study:

  • To investigate the role of inflammatory mechanisms in neointimal proliferation and restenosis after coronary stenting.
  • To determine if individual inflammatory responses predict restenosis and event-free survival.
  • To assess the potential of anti-inflammatory therapies tailored to individual inflammatory status.

Main Methods:

  • Review of experimental studies from the past decade on inflammatory mechanisms in restenosis.

Related Experiment Videos

  • Analysis of the predictive value of acute local and systemic inflammatory responses to coronary stenting.
  • Evaluation of the impact of inflammatory status on the efficacy of anti-inflammatory therapies (statins, steroids).

    • Main Results:

    • Individual inflammatory responses to coronary stenting are highly variable and predictive of restenosis and event-free survival.
    • The effectiveness of anti-inflammatory therapies and long-term follow-up is contingent upon a patient's specific inflammatory status.
    • Measurement of acute-phase reactants, such as C-reactive protein, is important for identifying high-risk individuals.

    Conclusions:

    • Inflammation is a critical factor in post-stent restenosis.
    • Personalized anti-inflammatory treatment strategies, guided by individual inflammatory markers, are essential for optimizing outcomes after coronary stenting.
    • C-reactive protein measurement can aid in risk stratification and personalized treatment development.